News 18 Mar 2024 Sedimentum becomes Helpany as it expands into the USA Sedimentum has changed its name to Helpany and is expanding into San Francisco. At the same time, the medtech startup is unveiling its new radar-...
Aktuell 18 Mar 2024 Sedimentum expandiert als Helpany in die USA Sedimentum benennt sich um in Helpany und expandiert nach San Francisco. Das Medtech-Start-up präsentiert zugleich sein neues radargestütztes Sic...
News 26 Mar 2024 Top Stories from Western Switzerland (March 2024) From innovative approaches in cardiac care and sustainable plastics to enhancing spinal cord injury therapies and advancing virtual power plants,...
Actualités 26 Mar 2024 Les Grands Titres de Suisse occidentale (Mars 2024) D’approches innovantes en matière de soins cardiaques et de plastiques durables à l’amélioration des thérapies pour les lésions de la moelle épin...
News 02 Ott 2023 10 innovative healthcare startups in Greater Zurich to watch In the Greater Zurich Area, innovative healthcare innovations are being developed, produced, and launched to the market. We introduce 10 key play...
Mini SWISS Pavilion mini SWISS Pavilion @ Global Health Exhibition 2024 22 Ott 2024–24 Ott 2024 Malham Arabia Saudita
Novità 02 Giu 2023 Le ultime ricerche indicano che il 20% delle aziende biotecnologiche europee ha attualmente sede in Svizzera Press release Una nuova ricerca condotta da IQVIA e pubblicata recentemente nello Swiss Biotech Report 2023 mostra che il 20% delle aziende biotecnologiche eur...
Actualités 05 Set 2023 Neurosoft innove avec sa technologie pionnière d’interface cérébrale Basée au Campus Biotech à Genève, Neurosoft Bioelectronics a réalisé avec succès un essai clinique révolutionnaire de sa grille d'électrodes exte...
Headquarters 15 Giu 2023 Open Your HQ Are you a biopharmaceutical company seeking to access the European market? Switzerland could be the perfect location for your commercial headquar...
News 24 Mag 2023 Latest research shows 20% of European biotechs now headquartered in Switzerland Press release New research conducted by IQVIA and recently published in the 2023 Swiss Biotech Report shows that 20% of European biotech companies are now head...
Actualités 02 Giu 2023 UNE ÉTUDE RÉCENTE MONTRE QUE 20 % DES SOCIÉTÉS DE BIOTECHNOLOGIE EUROPÉENNES ONT DÉSORMAIS LEUR SIÈGE EN SUISSE Press release Une nouvelle étude menée par IQVIA et récemment publiée dans le Swiss Biotech Report 2023 montre que 20 % des sociétés de biotechnologie eur...
Informazioni paese 07 Dic 2023 Cina: parchi industriali e cluster nel Delta del Fiume delle Perle Grazie alla sua storia, alla sua apertura al mondo e al suo forte spirito imprenditoriale, la provincia di Guangdong, e più in generale la «Great...
News 20 Feb 2023 Limula and CSEM collaborate to make cellular therapies more accessible To improve the accessibility of cellular therapies using automation, Limula has received support from the CSEM from the prototyping phase to the ...